[The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma]
- PMID: 17553309
[The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma]
Abstract
Objective: To study the expression of stromal cell derived factor-1 (SDF-1) and its receptor CXCR4 in non-Hodgkin lymphoma (NHL), and to investigate the role of this biological axis in tumor metastasis of NHL.
Methods: Specimens of bone marrow were collected from 4 patients with NHL with bone marrow infiltration and 4 cases of NHL without bone marrow infiltration, and 4 patients with benign hepatopathy with normal myelogram. Lymphoma specimens were collected from 7 cases of NHL and 3 cases of reactive proliferative lymphadenitis. The level of SDF-1alpha mRNA in the stromal cells of bone marrow and lymph node were determined by RT-PCR. The CXCR4 expression on lymphoma cells freshly isolated from bone marrow and lymph node of the NHL patients were studied by flow cytometry. Transwell assay was performed, the upper chamber being added with suspension of cells newly isolated from lymph nodes or bone marrow undergoing co-incubation with ant-CXCR4 monoclonal antibody or not, and the lower chamber added with culture fluid with or without recombinant human SDF-1alpha (rhSDF-1alpha). The migration rate of the primary lymphoma cells towards rhSDF-1alpha was calculated.
Results: The expression levels of CXCR4 on the lymphoma cells isolated from the bone marrow involved or not involved by NHL were both significantly higher than that of the mononuclear cells from normal bone marrow (both P < 0.01), whereas the CXCR4 expression level on the lymphoma cells from the lymph nodes of the NHL patients was also significantly higher than that of the mononuclear cells from the lymph nodes of reactive proliferative lymphadenitis (P < 0.01). The SDF-1alpha mRNA expression level in the stromal cells isolated from the bone marrow involved by NHL was significantly higher than those of the stromal cells of bone marrow not involved by NHL and the normal bone marrow (both P < 0.01). Moreover, the SDF-1alpha expression level in the lymph node stromal cells of all the NHL patients was also significantly higher than that of the patients with reactive proliferative lymphadenitis (P < 0.01). Transwell assay revealed that all three kinds of primary lymphoma cells migrated towards rhSDF-1alpha effectively, and this migration was markedly inhibited by the addition of anti-CXCR4 monoclonal antibody to the lymphoma cells (all P < 0.01).
Conclusion: SDF-1/CXCR4 axis plays a uniquely important biological role in mediating tumor metastasis of NHL.
Similar articles
-
Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.Acta Pharmacol Sin. 2006 Nov;27(11):1438-46. doi: 10.1111/j.1745-7254.2006.00415.x. Acta Pharmacol Sin. 2006. PMID: 17049119
-
[Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].Zhonghua Yi Xue Za Zhi. 2008 Jan 15;88(3):202-5. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18361822 Chinese.
-
[Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):260-4. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615279 Chinese.
-
Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.Stem Cells. 2005 Aug;23(7):879-94. doi: 10.1634/stemcells.2004-0342. Epub 2005 May 11. Stem Cells. 2005. PMID: 15888687 Review.
-
Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.Exp Hematol. 2006 Aug;34(8):967-75. doi: 10.1016/j.exphem.2006.04.002. Exp Hematol. 2006. PMID: 16863903 Review.
Cited by
-
SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis.Onco Targets Ther. 2017 Mar 14;10:1575-1583. doi: 10.2147/OTT.S130086. eCollection 2017. Onco Targets Ther. 2017. PMID: 28352190 Free PMC article.
-
CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.J Clin Lab Anal. 2009;23(6):387-93. doi: 10.1002/jcla.20346. J Clin Lab Anal. 2009. PMID: 19927352 Free PMC article.
-
Double-Targeted Knockdown of miR-21 and CXCR4 Inhibits Malignant Glioma Progression by Suppression of the PI3K/AKT and Raf/MEK/ERK Pathways.Biomed Res Int. 2020 Oct 15;2020:7930160. doi: 10.1155/2020/7930160. eCollection 2020. Biomed Res Int. 2020. PMID: 33123586 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources